Evidence map›Paper›PMID 27802818›Full record

ArticleDiagnostic pathology2016

Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.

Hossein Ajdarkosh, Masoomeh Dadpay, Emad Yahaghi, Elham Rostami Pirzaman, Amir Farshid Fayyaz, Ebrahim Khodaverdi Darian, Aram Mokarizadeh

Abstract readRetraction Notice
In one paragraph

Article in Diagnostic pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hossein AjdarkoshGastrointestinal and Liver Disease Research Center (GILDRC), Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Masoomeh DadpayDepartment of Pathology, Imam Reza Hospital, AJA University of Medical Sciences, Tehran, Iran.
Emad YahaghiBaqiyatallah University of Medical Sciences, Tehran, Iran.
Elham Rostami PirzamanDepartment of Biotechnology and Nanotechnology, Zanjan University of Medical Sciences, Zanjan, Iran.
Amir Farshid FayyazDepartment of Legal Medicine, AJA University of Medical Sciences, Tehran, Iran.
Ebrahim Khodaverdi DarianYoung Researchers and Elite Club, Karaj Branch, Islamic Azad University, Karaj, Iran.
Aram MokarizadehCellular & Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran. a.mokarizadeh@muk.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27802818
PMCPMC5090897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.